Christopher Tucker

1.0k total citations
26 papers, 773 citations indexed

About

Christopher Tucker is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Christopher Tucker has authored 26 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Immunology and 5 papers in Genetics. Recurrent topics in Christopher Tucker's work include Cancer Immunotherapy and Biomarkers (8 papers), Immune Cell Function and Interaction (6 papers) and Diabetes and associated disorders (4 papers). Christopher Tucker is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immune Cell Function and Interaction (6 papers) and Diabetes and associated disorders (4 papers). Christopher Tucker collaborates with scholars based in United States, United Kingdom and Canada. Christopher Tucker's co-authors include Brian T. Fife, Tijana Martinov, Jason S. Mitchell, Andrew D. Weinberg, James Kelly, Justin A. Spanier, Lee J. Wylie, Paul G. Winyard, Andrew M. Jones and Stephen J. Bailey and has published in prestigious journals such as Journal of Clinical Oncology, Immunity and Nature Immunology.

In The Last Decade

Christopher Tucker

24 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Tucker United States 13 302 250 157 142 102 26 773
Zhan Shi China 14 170 0.6× 120 0.5× 175 1.1× 43 0.3× 98 1.0× 24 663
Mineko Tsuruoka Japan 6 482 1.6× 215 0.9× 238 1.5× 54 0.4× 43 0.4× 7 916
Bora Han United States 10 419 1.4× 217 0.9× 156 1.0× 71 0.5× 56 0.5× 22 894
Longsheng Hong United States 13 143 0.5× 303 1.2× 357 2.3× 77 0.5× 132 1.3× 22 965
Miriam Eckstein United States 16 391 1.3× 139 0.6× 503 3.2× 51 0.4× 66 0.6× 20 1.2k
Ping Bo China 13 109 0.4× 111 0.4× 625 4.0× 70 0.5× 87 0.9× 33 964
Mika Terao Japan 20 278 0.9× 86 0.3× 351 2.2× 66 0.5× 64 0.6× 42 1.1k
Pattatheyil Arun India 17 121 0.4× 337 1.3× 457 2.9× 34 0.2× 148 1.5× 50 947

Countries citing papers authored by Christopher Tucker

Since Specialization
Citations

This map shows the geographic impact of Christopher Tucker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Tucker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Tucker more than expected).

Fields of papers citing papers by Christopher Tucker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Tucker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Tucker. The network helps show where Christopher Tucker may publish in the future.

Co-authorship network of co-authors of Christopher Tucker

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Tucker. A scholar is included among the top collaborators of Christopher Tucker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Tucker. Christopher Tucker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mitchell, Jason S., Justin A. Spanier, Todd P. Knutson, et al.. (2024). CD4+ T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetes. Immunity. 57(10). 2399–2415.e8. 6 indexed citations
2.
Tucker, Christopher, et al.. (2021). The Role of Programmed Death-1 in Type 1 Diabetes. Current Diabetes Reports. 21(6). 20–20. 12 indexed citations
3.
Mitchell, Jason S., et al.. (2021). Enhanced CD4+ and CD8+ T cell infiltrate within convex hull defined pancreatic islet borders as autoimmune diabetes progresses. Scientific Reports. 11(1). 17142–17142. 12 indexed citations
4.
Williams, Jesse W., Konstantin Zaitsev, Ki-Wook Kim, et al.. (2020). Limited proliferation capacity of aortic intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression. Nature Immunology. 21(10). 1194–1204. 138 indexed citations
5.
Tucker, Christopher, Jason S. Mitchell, Tijana Martinov, et al.. (2020). Adoptive T Cell Therapy with IL-12–Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for Autoimmunity. The Journal of Immunology. 205(5). 1449–1460. 20 indexed citations
6.
Tucker, Christopher, Soumyaroop Bhattacharya, Hironao Wakabayashi, et al.. (2018). Transcriptional Regulation on Aneuploid Chromosomes in Diverse Candida albicans Mutants. Scientific Reports. 8(1). 1630–1630. 14 indexed citations
7.
Wakabayashi, Hironao, Christopher Tucker, Anatoliy Kravets, et al.. (2017). NuA4 histone acetyltransferase activity is required for H4 acetylation on a dosage-compensated monosomic chromosome that confers resistance to fungal toxins. Epigenetics & Chromatin. 10(1). 52–52. 5 indexed citations
8.
Rendas‐Baum, Regina, et al.. (2016). Mapping the Irritable Bowel Syndrome Quality of Life Measure (IBS-QOL) to EQ-5D in Patients with Irritable Bowel Syndrome with Diarrhoea (IBS-D). Value in Health. 19(7). A379–A379. 1 indexed citations
9.
Montler, Ryan, R. Bryan Bell, Colin Thalhofer, et al.. (2016). OX40, PD‐1 and CTLA‐4 are selectively expressed on tumor‐infiltrating T cells in head and neck cancer. Clinical & Translational Immunology. 5(4). e70–e70. 90 indexed citations
10.
Richardson, Russell S., J. S. Leigh, Peter D. Wagner, et al.. (2015). consumption in trained human skeletal muscle.
11.
Tucker, Christopher, et al.. (2015). Comparison of anti-OX40 to PD-1 and CTLA-4 blockade in T cell immunization/priming models (TUM3P.1047). The Journal of Immunology. 194(1_Supplement). 70.4–70.4. 2 indexed citations
12.
Dong, Hongxin, Shirlene Wang, Ziling Zeng, et al.. (2014). Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice. Psychopharmacology. 231(24). 4711–4722. 38 indexed citations
13.
Montler, Ryan, R. Bryan Bell, Rom S. Leidner, et al.. (2014). OX40 and other immunoregulatory molecules are highly expressed on tumor infiltrating lymphocytes in oral, head and neck squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 2(S3). 2 indexed citations
14.
Kelly, James, Anni Vanhatalo, Stephen J. Bailey, et al.. (2014). Dietary nitrate supplementation: effects on plasma nitrite and pulmonary O2 uptake dynamics during exercise in hypoxia and normoxia. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 307(7). R920–R930. 93 indexed citations
15.
Kovacsovics‐Bankowski, Magdalena, Lana Chisholm, Christopher Tucker, et al.. (2014). Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similarities. Journal for ImmunoTherapy of Cancer. 2(1). 32 indexed citations
16.
Pastorino, Sandra, Sandeep C. Pingle, Emma Langley, et al.. (2014). Abstract 4652: Cerebrospinal fluid pharmacokinetics and pharmacodynamics following high-dose erlotinib treatment in brain cancer patients. Cancer Research. 74(19_Supplement). 4652–4652. 1 indexed citations
17.
Buie, Larry W., Celeste Lindley, Tiffany Ting‐Fang Shih, et al.. (2007). Plasma pharmacokinetics and cerebrospinal fluid concentrations of erlotinib in high-grade gliomas: A novel, phase I, dose escalation study. Journal of Clinical Oncology. 25(18_suppl). 2054–2054. 9 indexed citations
18.
Waterhouse, Dawn, Richard Klasa, Euan Ramsay, et al.. (2006). Development and Assessment of Conventional and Targeted Drug Combinations for Use in the Treatment of Aggressive Breast Cancers. Current Cancer Drug Targets. 6(6). 455–489. 32 indexed citations
19.
Reckamp, Karen L., Kostyantyn Krysan, Jason D. Morrow, et al.. (2006). A Phase I Trial to Determine the Optimal Biological Dose of Celecoxib when Combined with Erlotinib in Advanced Non–Small Cell Lung Cancer. Clinical Cancer Research. 12(11). 3381–3388. 87 indexed citations
20.
Raza, Azra, Harvey D. Preisler, Beatrice C. Lampkin, et al.. (1991). Biological significance of cell cycle kinetics in 128 standard risk newly diagnosed patients with acute myelocytic leukaemia. British Journal of Haematology. 79(1). 33–39. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhan Shi Breakdown of academic impact, for papers by Mineko Tsuruoka Breakdown of academic impact, for papers by Bora Han Breakdown of academic impact, for papers by Longsheng Hong Breakdown of academic impact, for papers by Miriam Eckstein Breakdown of academic impact, for papers by Ping Bo Breakdown of academic impact, for papers by Mika Terao Breakdown of academic impact, for papers by Pattatheyil Arun
Rankless by CCL
2026